Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-15

Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies [NA]

View source ↗

Summary

This clinical trial investigates allogeneic hematopoietic stem cell transplantation as a treatment for primary immune deficiencies, including SCID and related d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: SCID, Omenn's Syndrome | NA | Status: ACTIVE_NOT_RECRUITING